Dec 15 (Reuters) - Australia's competition regulator has killed the $1 billion takeover of Healius (HLS.AX) by rival Australian Clinical Labs (ACL.AX) in its fourth decision in the past year to block a big ticket merger.
July 20 (Reuters) - Australia's competition watchdog on Thursday raised concerns over Australian Clinical Labs' (ACL.AX) A$1.52 billion ($1.03 billion) buyout offer for medical centre operator Healius (HLS.AX), which had rejected the proposal in May.